Structure–release rate correlation in collagen gels containing fluorescent drug analog
Source abstract
Abstract
The paper examines the release properties of collagen gels that contain covalently bound fluorescent drug analogs. Collagen gels were prepared by fibrilogenesis. The gels were stabilized by cross linking with EDAC/NHS. SEM studies showed that increasing the cross-linking time with EDAC/NHS resulted in decreasing pore size and increasing gel density. Fluorescence spectroscopy measurements showed a clear correlation between decreasing pore size and increasing gel density, and lower release rate from the gels. Additives like chondrotitin-6-sulfate (CS) and amino acids altered the release properties of the cross-linked collagen gels. CS increased the stability of collagen gels to enzymatic degradation and non-enzymatic degradation. This was attributed to increasing gel rigidity due to carbohydrate-protein interactions. The amino acid lysine increased the stability of collagen gels which was attributed to increasing cross-linking level between the collagen fibrils and the primary amine group on the lysine side chain. The amino acid histidine decreased the stability of the gels, particularly to non-enzymatic degradation. These results correlated with increasing pore size following treatment with histidine. Our study shows, for the first time, a clear correlation between structure and release properties of collagen gels. It describes in detail the effect of additives on the structural and release properties of collagen gels. The study focused on gels that were prepared through fibrillogenesis and were therefore similar in structure to native collagen.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Collagen: Extraction and Characterization · Osteoarthritis Treatment and Mechanisms · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (30)
Show source-provided references
1. Brownwald F, Kasper H, Longo J. Principles of internal medicine Harrison's 15th ed., vol. 1. New York: McGraw-Hill Medical Publishing Division; 2001. p. 451–554.
2. Drug targeting10.1016/S0928-0987(00)00166-4 ↗
3. Biomedical applications of collagen10.1016/S0378-5173(01)00691-3 ↗
4. Controlled release of vascular endothelial growth factor by use of collagen hydrogels10.1163/156856200744101 ↗
5. Modeling of drug release from collagen matrices10.1002/jps.10098 ↗
6. Diffusion characteristics of collagen film10.1016/S0168-3659(01)00467-9 ↗
7. Collagen gel systems for sustained delivery and tissue engineering10.1016/j.addr.2003.08.004 ↗
8. Collagen as a carrier for on-site delivery of antibacterial drugs10.1016/j.addr.2003.08.007 ↗
9. Thermal dehydration treatment and gluteraldehyde cross linking to increase the biostability of collagen–chitosan porous scaffolds used as dermal equivalent10.1163/156856203768366576 ↗
10. Recombinant collagen and gelatin for drug delivery10.1016/j.addr.2003.08.008 ↗
11. Collagenous matrices as release carriers of exogenous growth factors10.1016/j.biomaterials.2003.11.035 ↗
12. Degradation of a collagen–chondroitin-6-sulfate matrix by collagenase and by chondroitinase10.1016/S0142-9612(03)00541-6 ↗
13. Preparation and characterization of porous cross-linked collagenous matrices containing bioavailable chondroitin sulphate10.1016/S0142-9612(98)00240-3 ↗
14. Enhanced biological stability of collagen porous scaffolds by using amino acids as novel cross-linking bridges10.1016/j.biomaterials.2003.09.092 ↗
15. Improved collagen bilayer dressing for the controlled release of drugs10.1002/jbm.b.30051 ↗
16. Characterization of collagen gel solution and collagen matrices for cell culture10.1016/S0142-9612(00)00315-X ↗
17. Investigation into the biological stability of collagen/chondroitin-6-slphate gels and their contraction by fibroblasts and keratinocytes: the effect of crosskinking agents and diamines10.1016/S0142-9612(98)00179-3 ↗
18. Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid10.1016/S0264-410X(01)00039-1 ↗
19. An infection-preventing bilayered collagen membrane containing antibiotic-loaded hyaluronan microparticles: physical and biological properties10.1046/j.1525-1594.2002.06847.x ↗
20. Denaturated thiolated collagen10.1016/S0142-9612(97)00003-3 ↗
21. Hermanson · 1996
22. In vitro degradation of dermal sheep collagen cross linked using a water-soluble carbodiimide10.1016/0142-9612(96)86737-8 ↗
23. Chondroitin-6-sulfate incorporated into collagen gels for the growth of human keratinocytes: the effect of cross-linking agents and diamines10.1016/0142-9612(96)81414-1 ↗
24. Collagen–proteoglycan interactions. Localization of proteoglycans intendon by electron microscopy10.1042/bj1870887 ↗
25. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium10.1016/S0006-3495(02)73933-7 ↗
26. Control of pH alters the type of cross-linking produced by 1ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) treatment of a cellular matrix vascular grafts
27. Matrix metalloproteinases: a review10.1177/10454411930040020401 ↗
28. Localized unfolding of collagen explains collagenase cleavage near imino-poor sites10.1016/S0022-2836(02)00421-7 ↗
29. Development of collagenase-resistant collagen and its interaction with adult human dermal fibroblasts10.1016/S0142-9612(03)00431-9 ↗
30. Combined gelatin–chondroitin sulfate hydrogels for controlled release of cationic antibacterial proteins10.1021/ma9917702 ↗